In a large cohort of 497 patients from the Atherosclerosis Risk in Communities Study elevated soluble ACE2 levels were associated with increased cardiac biomarkers, left ventricular hypertrophy, as well as risk for hospitalization because of heart failure, risk for cardiovascular disease events and death (Hussain et al., 2021). This evidence concerns the gene ACE2 and heart failure.